183 results on '"Pahl H"'
Search Results
52. A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B.
- Author
-
Münzenmaier, A, primary, Lange, C, additional, Glocker, E, additional, Covacci, A, additional, Moran, A, additional, Bereswill, S, additional, Baeuerle, P A, additional, Kist, M, additional, and Pahl, H L, additional
- Published
- 1997
- Full Text
- View/download PDF
53. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo.
- Author
-
Schadendorf, D, primary, Kern, M A, additional, Artuc, M, additional, Pahl, H L, additional, Rosenbach, T, additional, Fichtner, I, additional, Nürnberg, W, additional, Stüting, S, additional, von Stebut, E, additional, Worm, M, additional, Makki, A, additional, Jurgovsky, K, additional, Kolde, G, additional, and Henz, B M, additional
- Published
- 1996
- Full Text
- View/download PDF
54. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.
- Author
-
Pahl, H L, primary, Krauss, B, additional, Schulze-Osthoff, K, additional, Decker, T, additional, Traenckner, E B, additional, Vogt, M, additional, Myers, C, additional, Parks, T, additional, Warring, P, additional, Mühlbacher, A, additional, Czernilofsky, A P, additional, and Baeuerle, P A, additional
- Published
- 1996
- Full Text
- View/download PDF
55. Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention.
- Author
-
Pahl, H L, primary, Sester, M, additional, Burgert, H G, additional, and Baeuerle, P A, additional
- Published
- 1996
- Full Text
- View/download PDF
56. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B
- Author
-
Pahl, H L, primary and Baeuerle, P A, additional
- Published
- 1995
- Full Text
- View/download PDF
57. Serum β2-Microglobulin for Staging and Monitoring of Multiple Myelomas and Other Non-Hodgkin Lymphomas
- Author
-
Poley, S., primary, Fateh-Moghadam, A., additional, Nüssler, V., additional, and Pahl, H., additional
- Published
- 1994
- Full Text
- View/download PDF
58. Structural analysis of the CD11b gene and phylogenetic analysis of the alpha-integrin gene family demonstrate remarkable conservation of genomic organization and suggest early diversification during evolution.
- Author
-
Fleming, J C, primary, Pahl, H L, additional, Gonzalez, D A, additional, Smith, T F, additional, and Tenen, D G, additional
- Published
- 1993
- Full Text
- View/download PDF
59. Maintaining telephone switching systems in Africa.
- Author
-
Pahl, H.
- Published
- 1992
- Full Text
- View/download PDF
60. STAT3 is constitutively active in some patients with Polycythemia rubra vera
- Author
-
Roder, S., Steimle, C., Meinhardt, G., and Pahl, H. L.
- Published
- 2001
- Full Text
- View/download PDF
61. Grundlagenforschung in einer klinischen Abteilung: M�glichkeiten und Grenzen.
- Author
-
Pahl, H. L.
- Published
- 2006
- Full Text
- View/download PDF
62. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65.
- Author
-
Lyss, G, Knorre, A, Schmidt, T J, Pahl, H L, and Merfort, I
- Abstract
The sesquiterpene lactone helenalin is a potent anti-inflammatory drug whose molecular mechanism of action remains unclear despite numerous investigations. We have previously shown that helenalin and other sesquiterpene lactones selectively inhibit activation of the transcription factor NF-kappaB, a central mediator of the human immune response. These drugs must target a central step in NF-kappaB pathway, since they inhibit NF-kappaB induction by four different stimuli. It has previously been reported that sesquiterpene lactones exert their effect by inhibiting degradation of IkappaB, the inhibitory subunit of NF-kappaB. These data contradicted our report that IkappaB is not detectable in helenalin-treated, ocadaic acid-stimulated cells. Here we use confocal laser scanning microscopy to demonstrate the presence of IkappaB-released, nuclear NF-kappaB in helenalin-treated, tumor necrosis factor-alpha stimulated cells. These data show that neither IkappaB degradation nor NF-kappaB nuclear translocation are inhibited by helenalin. Rather, we provide evidence that helenalin selectively alkylates the p65 subunit of NF-kappaB. This sesquiterpene lactone is the first anti-inflammatory agent shown to exert its effect by directly modifying NF-kappaB.
- Published
- 1998
63. MyD88, an adapter protein involved in interleukin-1 signaling.
- Author
-
Burns, K, Martinon, F, Esslinger, C, Pahl, H, Schneider, P, Bodmer, J L, Di Marco, F, French, L, and Tschopp, J
- Abstract
MyD88 has a modular organization, an N-terminal death domain (DD) related to the cytoplasmic signaling domains found in many members of the tumor necrosis factor receptor (TNF-R) superfamily, and a C-terminal Toll domain similar to that found in the expanding family of Toll/interleukin-1-like receptors (IL-1R). This dual domain structure, together with the following observations, supports a role for MyD88 as an adapter in IL-1 signal transduction; MyD88 forms homodimers in vivo through DD-DD and Toll-Toll interactions. Overexpression of MyD88 induces activation of the c-Jun N-terminal kinase (JNK) and the transcription factor NF-kappaB through its DD. A point mutation in MyD88, MyD88-lpr (F56N), which prevents dimerization of the DD, also blocks induction of these activities. MyD88-induced NF-kappaB activation is inhibited by the dominant negative versions of TRAF6 and IRAK, which also inhibit IL-1-induced NF-kappaB activation. Overexpression of MyD88-lpr or MyD88-Toll (expressing only the Toll domain) acted to inhibit IL-1-induced NF-kappaB and JNK activation in a 293 cell line overexpressing the IL-1RI. MyD88 coimmunoprecipitates with the IL-1R signaling complex in an IL-1-dependent manner.
- Published
- 1998
64. Endoplasmic-Reticulum-Induced Signal Transduction and Gene Expression
- Author
-
Pahl, H. L. and Baeuerle, P. A.
- Published
- 1997
- Full Text
- View/download PDF
65. Bemessung von Bauten und Bauteilen gegen konventionelle Waffenwirkung. Tl.V
- Author
-
Pahl, H. and Publica
- Subjects
Luftstoßparameter ,Schutzbau ,Strukturschaden ,Schaden(lokal) - Published
- 1986
66. A Sensitive Emission Spectrographic Method for the Analysis of High Purity Mercury
- Author
-
Pahl, H. R., primary
- Published
- 1972
- Full Text
- View/download PDF
67. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation.
- Author
-
Glocker, E, Lange, C, Covacci, A, Bereswill, S, Kist, M, and Pahl, H L
- Abstract
Helicobacter pylori is the etiological agent in the development of chronic gastritis, duodenal ulceration, and gastric adenocarcinoma. The difference in virulence between individual strains is reflected in their ability to induce interleukin-8 (IL-8) secretion from gastric epithelial cells. It has been shown that virulence is associated with the presence of a bacterial gene cluster (a pathogenicity island). We have recently demonstrated that H. pylori-mediated IL-8 secretion requires activation of the transcription factor NF-kappaB. Here, we show that NF-kappaB induction requires six membrane proteins encoded within the pathogenicity island.
- Published
- 1998
68. Control of gene expression by proteolysis
- Author
-
Pahl, H
- Published
- 1996
- Full Text
- View/download PDF
69. Regulation of the transcription factors NF-kappaB and AP-1 by redox changes
- Author
-
Meyer, M., Pahl, H. L., and Baeuerle, P. A.
- Published
- 1994
- Full Text
- View/download PDF
70. Anti-inflammatory activities of hypocretenolides from Leontopodium hispidus
- Author
-
Hermann Stuppner, R. Della Loggia, Christian Zidorn, Verena M. Dirsch, Silvio Sosa, Irmgard Merfort, Heike L. Pahl, Peter Rüngeler, Angelika M. Vollmar, Zidorn, C., V. M., Dirsch, Rungeler, P., Sosa, Silvio, DELLA LOGGIA, Roberto, Merfort, I., Pahl, H. L., Vollmar, A. M., and Stuppner, H.
- Subjects
Pharmaceutical Science ,Leontodon hispidus ,Cell Line ,Analytical Chemistry ,Nitric oxide ,Jurkat Cells ,Mice ,chemistry.chemical_compound ,Drug Discovery ,Animals ,Humans ,Electrophoretic mobility shift assay ,Nitrites ,Pharmacology ,Plants, Medicinal ,biology ,Anti-Inflammatory Agents, Non-Steroidal ,Organic Chemistry ,NF-kappa B ,Biological activity ,DNA ,In vitro ,Nitric oxide synthase ,Aglycone ,Complementary and alternative medicine ,chemistry ,Biochemistry ,Cell culture ,biology.protein ,Molecular Medicine ,Sesquiterpenes - Abstract
Hypocretenolides, a small group of sesquiterpene lactones with an unusual ring structure, are constituents of a small number of species from the Lactuceae tribe (Asteraceae). Three biogenetically closely related 14-hypocretenolides from Leontodon hispidus L. were investigated for a putative anti-inflammatory activity. 14-Hydroxyhypocretenolide-beta-D-glucoside-4'-14"-hydroxyhypocr etenoate significantly exhibited in vivo anti-inflammatory activity in the croton oil-induced mouse ear edema. To obtain first information regarding the molecular targets which might be affected by this constituent, two in vitro bioassays were performed: (i) DNA binding activity of the transcription factor NF-kappa B was evaluated by electrophoretic mobility shift assay (EMSA) using TNF-alpha-activated Jurkat T cells and (ii) nitrite accumulation in cell culture supernatants of LPS-activated RAW 264.7 macrophages was determined as a parameter for inducible nitric oxide synthase (iNOS)-dependent nitric oxide release. In order to gain information about structure-activity relationships, additionally the aglycone 14-hydroxyhypocretenolide and its D-glycoside were investigated in these in vitro systems. 14-Hydroxyhypocretenolide-beta-D-glucoside-4'-14"-hydroxyhypocr etenoate as well as its aglycone exhibited activity in both test systems, whereas the D-glucoside was not or only weakly active.
- Published
- 1999
71. Randomized controlled trial investigating the effectiveness of a multimodal mobile application for the treatment of chronic pain.
- Author
-
Thomson CJ, Pahl H, and Giles LV
- Abstract
Background: Until recently, treatments for chronic pain commonly relied on in-person interventions, and despite more hybrid care options today, capacity for delivery remains challenged. Digital programs focusing on the psychosocial aspects of pain may provide low-barrier alternatives., Aims: Through a randomized controlled trial, we investigated the effectiveness of a multimodal mobile application., Methods: Participants ( n = 198; 82% women, mean age = 46.7 [13.1] years; mean pain duration 13.6 [11.2] years) with nonmalignant chronic pain were randomized to either a 6-week intervention ( n = 98) or a wait-listed usual care group ( n = 100). The intervention involved regular engagement with a user-guided mobile application (Curable Inc.) informed by the biopsychosocial model of pain that included pain education, meditation, cognitive behavioral therapy, and expressive writing. The co-primary outcomes were pain severity and interference at 6 weeks., Results: We observed significant improvements in the intervention group compared to the control group with estimated changes of -0.67 (95% confidence interval [CI] -1.04 to -0.29, P < .001, d = 0.43) and -0.60 (95% CI -1.18 to -0.03, P = .04, d = 0.27) for pain severity and interference, respectively. There were significant improvements across secondary outcomes (Patient-Reported Outcome Measurement Information System pain interference; pain catastrophizing; anxiety, depression; stress). Frequency of app use was correlated with improved pain interference ( P < .001) and pain catastrophizing (P = 0.018), and changes from baseline persisted in the intervention group at 12 weeks ( P < .05)., Conclusions: A short-term mobile app intervention resulted in significant improvements across physical and mental health outcomes compared to wait-listed usual care., Competing Interests: No potential conflict of interest was reported by the author(s)., (© 2024 The Author(s). Published with license by Taylor & Francis Group, LLC.)
- Published
- 2024
- Full Text
- View/download PDF
72. New C3H Kit N824K/WT cancer mouse model develops late-onset malignant mammary tumors with high penetrance.
- Author
-
Klein-Rodewald T, Micklich K, Sanz-Moreno A, Tost M, Calzada-Wack J, Adler T, Klaften M, Sabrautzki S, Aigner B, Kraiger M, Gailus-Durner V, Fuchs H, Gründer A, Pahl H, Wolf E, Hrabe de Angelis M, and Rathkolb B
- Subjects
- Mice, Female, Humans, Animals, Penetrance, Mice, Inbred C3H, Proto-Oncogene Proteins c-kit genetics, Disease Models, Animal, Gastrointestinal Stromal Tumors genetics, Breast Neoplasms genetics
- Abstract
Gastro-intestinal stromal tumors and acute myeloid leukemia induced by activating stem cell factor receptor tyrosine kinase (KIT) mutations are highly malignant. Less clear is the role of KIT mutations in the context of breast cancer. Treatment success of KIT-induced cancers is still unsatisfactory because of primary or secondary resistance to therapy. Mouse models offer essential platforms for studies on molecular disease mechanisms in basic cancer research. In the course of the Munich N-ethyl-N-nitrosourea (ENU) mutagenesis program a mouse line with inherited polycythemia was established. It carries a base-pair exchange in the Kit gene leading to an amino acid exchange at position 824 in the activation loop of KIT. This KIT variant corresponds to the N822K mutation found in human cancers, which is associated with imatinib-resistance. C3H Kit
N824K/WT mice develop hyperplasia of interstitial cells of Cajal and retention of ingesta in the cecum. In contrast to previous Kit-mutant models, we observe a benign course of gastrointestinal pathology associated with prolonged survival. Female mutants develop mammary carcinomas at late onset and subsequent lung metastasis. The disease model complements existing oncology research platforms. It allows for addressing the role of KIT mutations in breast cancer and identifying genetic and environmental modifiers of disease progression., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
73. Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.
- Author
-
Mascarenhas J, Baer MR, Kessler C, Hexner E, Tremblay D, Price L, Sandy L, Weinberg R, Pahl H, Silverman LR, Goldberg JD, Kosiorek H, Dueck AC, and Hoffman R
- Subjects
- Carbazoles administration & dosage, Carbazoles adverse effects, Furans, Humans, Janus Kinase Inhibitors administration & dosage, Janus Kinase Inhibitors adverse effects, Primary Myelofibrosis diagnosis, Primary Myelofibrosis metabolism, Treatment Outcome, Carbazoles therapeutic use, Janus Kinase 2 antagonists & inhibitors, Janus Kinase Inhibitors therapeutic use, Primary Myelofibrosis drug therapy
- Published
- 2019
- Full Text
- View/download PDF
74. Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression.
- Author
-
Klein C, Zwick A, Kissel S, Forster CU, Pfeifer D, Follo M, Illert AL, Decker S, Benkler T, Pahl H, Oostendorp RA, Aumann K, Duyster J, and Dierks C
- Subjects
- Animals, Disease Progression, Hedgehog Proteins metabolism, Hematopoiesis, Hematopoietic Stem Cells metabolism, Hematopoietic Stem Cells pathology, Humans, Janus Kinase 2 genetics, Janus Kinase 2 metabolism, Leukemia etiology, Leukemia genetics, Leukemia metabolism, Ligands, Lymphopenia etiology, Mice, Mice, Knockout, Mice, Transgenic, Mutant Proteins genetics, Mutant Proteins metabolism, Myeloproliferative Disorders genetics, Myeloproliferative Disorders metabolism, Osteoblasts metabolism, Osteoblasts pathology, Patched Receptors, Patched-2 Receptor, Phenotype, Polycythemia Vera genetics, Polycythemia Vera metabolism, Polycythemia Vera pathology, Receptors, Cell Surface genetics, Recombinant Proteins genetics, Recombinant Proteins metabolism, Signal Transduction, Stem Cell Niche, Myeloproliferative Disorders etiology, Receptors, Cell Surface deficiency
- Abstract
JAK2V617F(+) myeloproliferative neoplasms (MPNs) frequently progress into leukemias, but the factors driving this process are not understood. Here, we find excess Hedgehog (HH) ligand secretion and loss of PTCH2 in myeloproliferative disease, which drives canonical and noncanonical HH-signaling. Interestingly, Ptch2(-/-) mice mimic dual pathway activation and develop a MPN-phenotype with leukocytosis (neutrophils and monocytes), strong progenitor and LKS mobilization, splenomegaly, anemia, and loss of lymphoid lineages. HSCs exhibit increased cell cycling with improved stress hematopoiesis after 5-FU treatment, and this results in HSC exhaustion over time. Cytopenias, LKS loss, and mobilization are all caused by loss of Ptch2 in the niche, whereas hematopoietic loss of Ptch2 drives leukocytosis and promotes LKS maintenance and replating capacity in vitro. Ptch2(-/-) niche cells show hyperactive noncanonical HH signaling, resulting in reduced production of essential HSC regulators (Scf, Cxcl12, and Jag1) and depletion of osteoblasts. Interestingly, Ptch2 loss in either the niche or in hematopoietic cells dramatically accelerated human JAK2V617F-driven pathogenesis, causing transformation of nonlethal chronic MPNs into aggressive lethal leukemias with >30% blasts in the peripheral blood. Our findings suggest HH ligand inhibitors as possible drug candidates that act on hematopoiesis and the niche to prevent transformation of MPNs into leukemias., (© 2016 Klein et al.)
- Published
- 2016
- Full Text
- View/download PDF
75. [Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis].
- Author
-
Aumann K, Frey AV, May AM, Hauschke D, Kreutz C, Marx JP, Timmer J, Werner M, and Pahl HL
- Subjects
- Alleles, Biopsy, DNA Mutational Analysis, Diagnosis, Differential, Erythroid Precursor Cells pathology, Erythropoiesis genetics, Gene Expression Regulation, Neoplastic genetics, Humans, Leukocyte Count, Megakaryocytes pathology, Platelet Count, Polycythemia Vera genetics, Polycythemia Vera pathology, Reference Values, Thrombocytosis genetics, Thrombocytosis pathology, Awards and Prizes, Bone Marrow pathology, NF-E2 Transcription Factor, p45 Subunit analysis, NF-E2 Transcription Factor, p45 Subunit genetics, Primary Myelofibrosis genetics, Primary Myelofibrosis pathology, Thrombocythemia, Essential genetics, Thrombocythemia, Essential pathology
- Abstract
Background: Besides essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF) the myeloproliferative neoplasms (MPN) defined by the World Health Organization (WHO) comprise the entity of unclassifiable MPNs (MPN, U). The exact differential diagnosis of the specific MPN entities can be challenging particularly at early stages of the diseases. So far, pathologists have had to rely only on histomorphological evaluation of bone marrow biopsies in combination with laboratory data because helpful ancillary tests are not yet available. Even molecular tests, such as JAK2 mutation analysis are not helpful particularly in the differential diagnosis of ET and PMF because both entities are associated with the V617F mutation in 50 % of the cases. Recently overexpression of the transcription factor NF-E2 in MPN was described., Materials and Methods: A collective of samples consisting of 163 bone marrow biopsies including 139 MPN cases was stained immunohistochemically for NF-E2 and analyzed regarding the subcellular localization of NF-E2 in erythroid progenitor cells. The results were compared between the MPN entities as well as the controls and statistical analyses were conducted., Results and Discussion: This study showed that NF-E2 immunohistochemistry and analysis of the proportion of nuclear positive erythroblasts of all erythroid precursor cells can help to distinguish between ET and PMF even in early stages of the diseases. An MPN, U case showing a proportion of more than 20 % nuclear positive erythroblasts can be classified as a PMF with 92 % accuracy.
- Published
- 2013
- Full Text
- View/download PDF
76. Protective effects of inhaled carbon monoxide in pig lungs during cardiopulmonary bypass are mediated via an induction of the heat shock response.
- Author
-
Goebel U, Mecklenburg A, Siepe M, Roesslein M, Schwer CI, Pahl HL, Priebe HJ, Schlensak C, and Loop T
- Subjects
- Acute Lung Injury etiology, Acute Lung Injury pathology, Administration, Inhalation, Animals, Antioxidants therapeutic use, Carbon Monoxide therapeutic use, Heat-Shock Proteins metabolism, Hemodynamics physiology, Homeostasis physiology, Interleukin-6 metabolism, Ischemic Preconditioning methods, Lung metabolism, Lung pathology, Macrophages, Alveolar pathology, Quercetin therapeutic use, Random Allocation, Sus scrofa, Acute Lung Injury prevention & control, Carbon Monoxide pharmacology, Cardiopulmonary Bypass adverse effects, Heat-Shock Response drug effects
- Abstract
Background: Cardiopulmonary bypass (CPB) may cause acute lung injury leading to increased morbidity and mortality after cardiac surgery. Preconditioning by inhaled carbon monoxide reduces pulmonary inflammation during CPB. We hypothesized that inhaled carbon monoxide mediates its anti-inflammatory and cytoprotective effects during CPB via induction of pulmonary heat shock proteins (Hsps)., Methods: Pigs were randomized either to a control group, to standard CPB, to carbon monoxide+CPB, or to quercetin (a flavonoid and unspecific inhibitor of the heat shock response)+control, to quercetin+CPB, and to quercetin+carbon monoxide+CPB. In the carbon monoxide groups, lungs were ventilated with 250 ppm carbon monoxide in addition to standard ventilation before CPB. At various time points, lung biopsies were obtained and pulmonary Hsp and cytokine concentrations determined., Results: Haemodynamic parameters were largely unaffected by CPB, carbon monoxide inhalation, or administration of quercetin. Compared with standard CPB, carbon monoxide inhalation significantly increased the pulmonary expression of the Hsps 70 [27 (SD 3) vs 69 (10) ng ml(-1) at 120 min post-CPB, P<0.05] and 90 [0.3 (0.03) vs 0.52 (0.05) after 120 min CPB, P<0.05], induced the DNA binding of heat shock factor-1, reduced interleukin-6 protein expression [936 (75) vs 320 (138) at 120 min post-CPB, P<0.001], and decreased CPB-associated lung injury (assessed by lung biopsy). These carbon monoxide-mediated effects were inhibited by quercetin., Conclusions: As quercetin, a Hsp inhibitor, reversed carbon monoxide-mediated pulmonary effects, we conclude that the anti-inflammatory and protective effects of preconditioning by inhaled carbon monoxide during CPB in pigs are mediated by an activation of the heat shock response.
- Published
- 2009
- Full Text
- View/download PDF
77. [Basic research within clinical departments: opportunities and limits].
- Author
-
Pahl HL
- Subjects
- Anesthesiology trends, Academic Medical Centers, Biomedical Research
- Published
- 2006
- Full Text
- View/download PDF
78. Reduced activation of immunomodulatory transcription factors during positive end-expiratory pressure adjustment based on volume-dependent compliance in isolated perfused rabbit lungs.
- Author
-
Kirchner EA, Mols G, Hermle G, Muehlschlegel JD, Geiger KK, Guttmann J, and Pahl HL
- Subjects
- Animals, Cyclic AMP Response Element Modulator, DNA-Binding Proteins metabolism, Electrophoretic Mobility Shift Assay, Female, Lung immunology, Lung metabolism, Male, NF-kappa B metabolism, Rabbits, Respiratory Mechanics physiology, Tidal Volume, Transcription Factor AP-1 metabolism, Lung Compliance physiology, Positive-Pressure Respiration methods, Transcription Factors metabolism
- Abstract
Background: Repeated alveolar collapse and cyclic alveolar overdistension with associated activation of inflammatory signalling cascades contribute to ventilator-induced lung injury (VILI). The appropriate positive end-expiratory pressure (PEEP) which prevents or ameliorates VILI is unknown. In the isolated perfused lung, repeated adjustments of PEEP based on the continuously analysed intratidal compliance-volume curve have previously been shown to result in full end-expiratory alveolar recruitment and low risk of cyclic alveolar overdistension. Accordingly, we tested the hypothesis that such ventilatory management reduces intrapulmonary activation of the immunomodulatory transcription factors nuclear factor kappaB (NF-kappaB), activator protein 1 (AP-1) and cAMP-responsive element binding protein (CREB) which induce the expression of various chemokines and cytokines., Methods: Isolated perfused rabbit lungs were randomly allocated to one of three groups: zero end-expiratory pressure (ZEEP) to induce repeated alveolar collapse (n=6), high PEEP to induce cyclic alveolar overdistension (n=6) and repeated PEEP adjustments based on intratidal compliance-volume curve analysis by the slice method to minimize repeated alveolar collapse and overdistension (n=9). All lungs were ventilated with a tidal volume of 6 ml kg(-1) bodyweight for 120 min. Thereafter, activation of transcription factors NF-kappaB, AP-1 and CREB in lung tissue was analysed by electrophoretic mobility shift assay., Results: High PEEP was associated with the highest activation of NF-kappaB and AP-1 and repeated PEEP adjustments with the lowest activation when compared with the other two study groups (P<0.001). In contrast, activation of CREB did not differ between groups. Activated NF-kappaB and AP-1 protein complexes consisted mainly of the transactivators p50/p65 and c-Fos/Jun, respectively., Conclusions: In isolated perfused rabbit lungs, repeated adjustments of PEEP based on the continuously analysed intratidal compliance-volume curve were associated with less activation of early steps of inflammatory signalling cascades than ventilation with ZEEP or high PEEP.
- Published
- 2005
- Full Text
- View/download PDF
79. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones.
- Author
-
García-Piñeres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL, and Merfort I
- Subjects
- DNA-Binding Proteins metabolism, Drug Design, NF-KappaB Inhibitor alpha, Protein Binding, Protein Subunits, Quercetin pharmacology, Transcription Factor RelA, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Cysteine, DNA-Binding Proteins antagonists & inhibitors, I-kappa B Proteins, Lactones pharmacology, NF-kappa B antagonists & inhibitors, Sesquiterpenes pharmacology
- Abstract
Sesquiterpene lactones (SLs) have potent anti-inflammatory properties. We have shown previously that they exert this effect in part by inhibiting activation of the transcription factor NF-kappaB, a central regulator of the immune response. We have proposed a molecular mechanism for this inhibition based on computer molecular modeling data. In this model, SLs directly alkylate the p65 subunit of NF-kappaB, thereby inhibiting DNA binding. Nevertheless, an experimental evidence for the proposed mechanism was lacking. Moreover, based on experiments using the SL parthenolide, an alternative mode of action has been proposed by other authors in which SLs inhibit IkappaB-alpha degradation. Here we report the construction of p65/NF-kappaB point mutants that lack the cysteine residues alkylated by SLs in our model. In contrast to wild type p65, DNA-binding of the Cys(38) --> Ser and Cys(38,120) --> Ser mutants is no longer inhibited by SLs. In addition, we provide evidence that parthenolide uses a similar mechanism to other SLs in inhibiting NF-kappaB. Contrary to previous reports, we show that parthenolide, like other SLs, inhibits NF-kappaB most probably by alkylating p65 at Cys(38). Although a slight inhibition of IkappaB degradation was detected for all SLs, the amount of remaining IkappaB was too low to explain the observed NF-kappaB inhibition.
- Published
- 2001
- Full Text
- View/download PDF
80. Effect of nitric oxide on shock-induced hepatic heme oxygenase-1 expression in the rat.
- Author
-
Hoetzel A, Vagts DA, Loop T, Humar M, Bauer M, Pahl HL, Geiger KK, and Pannen BH
- Subjects
- Animals, Blood Pressure drug effects, Enzyme Inhibitors pharmacology, Gene Expression, HSP70 Heat-Shock Proteins metabolism, Heme Oxygenase (Decyclizing) genetics, Heme Oxygenase-1, Hemodynamics, Liver pathology, Male, Molsidomine pharmacology, NG-Nitroarginine Methyl Ester pharmacology, Nitric Oxide Donors pharmacology, Rats, Rats, Sprague-Dawley, Resuscitation, Shock, Hemorrhagic pathology, Shock, Hemorrhagic physiopathology, Transcription Factors metabolism, Heme Oxygenase (Decyclizing) metabolism, Liver metabolism, Nitric Oxide pharmacology, Shock, Hemorrhagic metabolism
- Abstract
Recent evidence suggests that the hepatic expression of heme oxygenase-1 (HO-1) may preserve hepatocellular integrity after hemorrhagic shock and resuscitation (HR). Because nitric oxide (NO) has been shown to modulate HO-1 expression in cultured cells in vitro, we determined its potential role in the regulation of HO-1 expression after HR in the rat liver in vivo. HO-1 mRNA and protein were highly induced and HO enzyme activity was higher after HR when compared with time-matched sham controls. Administration of the NO donor, molsidomine (MOL) (3 mg. kg(-1)), during resuscitation attenuated the accumulation of HO-1 mRNA and protein and the rise in HO activity. In addition, MOL prevented the shock-induced increase in DNA binding activity of the transcription factor, activator protein-1 (AP-1), but did not alter the activity of nuclear factor-erythroid 2 related factor (Nrf-2), nuclear transcription factor-kappaB (NF-kappaB), and hypoxia-inducible factor-1 (HIF-1). The suppressing action of MOL was not confined to HO-1, because the hepatic expression of the 70-kd major heat shock protein (HSP) in response to HR was also diminished. Moreover, MOL prevented the HR-induced increase in the serum activity of alanine transaminase (ALT) and alpha-glutathione-S-transferase (alpha-GST) that could otherwise be observed after HR. In contrast, the NO synthase inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME) (1 mg.kg(-1)), had either no or only minor effects on the primary experimental endpoints. These findings would be consistent with a reduction of shock-induced liver damage by exogenous NO, which in turn prevents the subsequent activation of injury-sensitive transcription factors, thus attenuating the expression of stress-inducible proteins such as HO-1.
- Published
- 2001
- Full Text
- View/download PDF
81. Inhibition of the transcription factor NF-kappa B by sesquiterpene lactones from Podachaenium eminens.
- Author
-
Castro V, Murillo R, Klaas CA, Meunier C, Mora G, Pahl HL, and Merfort I
- Subjects
- Humans, Jurkat Cells, Lactones chemistry, Asteraceae chemistry, Lactones pharmacology, NF-kappa B antagonists & inhibitors, Sesquiterpenes chemistry
- Abstract
Investigation of Podachaenium eminens afforded nine sesquiterpene lactones (Sls) from which costunolide, 7-hydroxycostunolide, santamarin as well as 3-chlorodehydroleucodin are new for this plant and 3,4-dehydro-4-dehydroxypodachaenin (= 3-costoyloxydehydroleucodin) is found for the first time in nature. All isolated Sls were studied for their anti-inflammatory activity using the transcription factor NF-kappa B as a molecular target. NF-kappa B is involved in the synthesis of inflammatory mediators, such as cytokines and chemokines. Except for podachaenin, all compounds completely inhibited NF-kappa B DNA binding in an electrophoretic mobility shift assay at concentrations between 5 and 200 microM without showing any cytotoxic effects. 3,4-Epoxydehydroleucodin possessing an alpha-methylene-gamma-butyrolactone and a second reactive structure element by its epoxy ring alpha,beta to a carbonyl group was most active. Although the majority of the Sls tested in this study were monofunctional only low concentrations of 50 microM were often needed for complete inhibition. Possible reasons are discussed for this result.
- Published
- 2000
- Full Text
- View/download PDF
82. Towards a molecular understanding of polycythemia rubra vera.
- Author
-
Pahl HL
- Subjects
- GPI-Linked Proteins, Growth Substances metabolism, Humans, Isoantigens, Membrane Glycoproteins, Myeloproliferative Disorders etiology, Myeloproliferative Disorders pathology, Phosphoprotein Phosphatases metabolism, Polycythemia Vera pathology, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-bcl-2 genetics, Proto-Oncogene Proteins c-bcl-2 metabolism, Receptors, Cell Surface genetics, Receptors, Erythropoietin metabolism, Receptors, Thrombopoietin, Stem Cells pathology, Stem Cells physiology, bcl-X Protein, Erythropoietin metabolism, Neoplasm Proteins, Polycythemia Vera etiology, Receptors, Cell Surface metabolism, Receptors, Cytokine, Signal Transduction
- Abstract
Polycythemia rubra vera (PV) is one of four diseases collectively called the myeloproliferative disorders (MPDs). Each disorder leads to an increased production of one or several hematopoietic cell lineages. MPDs arise from acquired mutations in a pluripotent hematopoietic stem cell. However, the molecular mechanisms leading to the development of these diseases are poorly understood. This review will summarize and evaluate recent advances in our understanding of one particular MPD, PV.
- Published
- 2000
- Full Text
- View/download PDF
83. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun.
- Author
-
Meyer-ter-Vehn T, Covacci A, Kist M, and Pahl HL
- Subjects
- Bacterial Proteins genetics, Bacterial Proteins pharmacology, Cell Transformation, Neoplastic genetics, DNA-Binding Proteins analysis, Enzyme Activation, Enzyme Inhibitors pharmacology, Gastric Mucosa metabolism, Gene Expression Regulation, Bacterial, Gene Expression Regulation, Neoplastic, Helicobacter pylori genetics, Helicobacter pylori pathogenicity, Humans, Mitogen-Activated Protein Kinases antagonists & inhibitors, Phosphorylation, Proto-Oncogene Mas, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-fos metabolism, Proto-Oncogene Proteins c-jun metabolism, RNA, Messenger metabolism, Signal Transduction, Tumor Cells, Cultured, ets-Domain Protein Elk-1, Antigens, Bacterial, Helicobacter pylori metabolism, Mitogen-Activated Protein Kinases metabolism, Proto-Oncogene Proteins c-fos genetics, Proto-Oncogene Proteins c-jun genetics, Transcription Factor AP-1 metabolism, Transcription Factors
- Abstract
Helicobacter pylori is an etiological agent in the development of mucosa-associated lymphoid tissue lymphoma and gastric adenocarcinoma. Patients infected with H. pylori carry a 3-6-fold increased risk of developing cancer compared with uninfected individuals. H. pylori strains expressing the cytotoxin-associated antigen A (CagA) are more frequently associated with the development of neoplasia than cagA-negative strains. However, the molecular mechanism by which H. pylori causes neoplastic transformation remains unclear. Here we report that exposure of gastric epithelial cells to H. pylori induces activation of the transcription factor activator protein 1. Activation of the proto-oncogenes c-fos and c-jun is strongly induced. We show that H. pylori activates the ERK/MAP kinase cascade, resulting in Elk-1 phosphorylation and increased c-fos transcription. H. pylori strains that do not express CagA or that are mutated in cag genes encoded by the CagI pathogenicity island do not induce activator protein 1, MAP kinase activity, or c-fos or c-jun activation. Proto-oncogene activation may represent a crucial step in the pathomechanism of H. pylori induced neoplasia.
- Published
- 2000
- Full Text
- View/download PDF
84. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera.
- Author
-
Temerinac S, Klippel S, Strunck E, Röder S, Lübbert M, Lange W, Azemar M, Meinhardt G, Schaefer HE, and Pahl HL
- Subjects
- Adult, Aged, Aged, 80 and over, Amino Acid Sequence, Cloning, Molecular, DNA, Complementary analysis, Female, Gene Expression, Granulocytes metabolism, Humans, Male, Middle Aged, Molecular Sequence Data, Organ Specificity, Polycythemia Vera blood, Receptors, Urokinase Plasminogen Activator, DNA, Complementary genetics, Polycythemia Vera genetics, Receptors, Cell Surface genetics
- Abstract
Polycythemia vera (PV) is a clonal stem cell disorder characterized by hyperproliferation of the erythroid, myeloid, and megakaryocytic lineages. Although it has been shown that progenitor cells of patients with PV are hypersensitive to several growth factors, the molecular pathogenesis of this disease remains unknown. To investigate the molecular defects underlying PV, we used subtractive hybridization to isolate complementary DNAs (cDNAs) differentially expressed in patients with PV versus normal controls. We isolated a novel gene, subsequently named PRV-1, which is highly expressed in granulocytes from patients with PV (n = 19), but not detectable in normal control granulocytes (n = 21). Moreover, PRV-1 is not expressed in mononuclear cells from patients with chronic myelogenous leukemia (n = 4) or acute myelogenous leukemia (n = 5) or in granulocytes from patients with essential thrombocythemia (n = 4) or secondary erythrocytosis (n = 4). Northern blot analysis showed that PRV-1 is highly expressed in normal human bone marrow and to a much lesser degree in fetal liver. It is not expressed in a variety of other tissues tested. Although PRV-1 is not expressed in resting granulocytes from normal controls, stimulation of these cells with granulocyte colony-stimulating factor induces PRV-1 expression. The PRV-1 cDNA encodes an open reading frame of 437 amino acids, which contains a signal peptide at the N-terminus and a hydrophobic segment at the C-terminus. In addition, PRV-1 contains 2 cysteine-rich domains homologous to those found in the uPAR/Ly6/CD59/snake toxin-receptor superfamily. We therefore propose that PRV-1 represents a novel hematopoietic receptor. (Blood. 2000;95:2569-2576)
- Published
- 2000
85. Assaying NF-kappa B and AP-1 DNA-binding and transcriptional activity.
- Author
-
Mueller JM and Pahl HL
- Subjects
- Animals, DNA metabolism, Humans, NF-kappa B genetics, Transcription Factor AP-1 genetics, NF-kappa B metabolism, Transcription Factor AP-1 metabolism, Transcription, Genetic
- Published
- 2000
- Full Text
- View/download PDF
86. Study of sesquiterpene lactones from Milleria quinqueflora on their anti-inflammatory activity using the transcription factor NF-kappa B as molecular target.
- Author
-
Castro V, Rüngeler P, Murillo R, Hernandez E, Mora G, Pahl HL, and Merfort I
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal isolation & purification, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Central America, Humans, Jurkat Cells, Lactones chemistry, Lactones isolation & purification, Lactones pharmacology, Medicine, Traditional, Models, Molecular, Molecular Conformation, Molecular Structure, Phytotherapy, Sesquiterpenes isolation & purification, Sesquiterpenes pharmacology, Anti-Inflammatory Agents, Non-Steroidal chemistry, Asteraceae chemistry, NF-kappa B antagonists & inhibitors, Plants, Medicinal, Sesquiterpenes chemistry
- Abstract
In Central America aerial parts of the Asteraceae Milleria quinqueflora are used in traditional medicine as a remedy for skin infections. Reinvestigation of this plant afforded thirteen sesquiterpene lactones (Sls), three of them are new. All isolated Sls were studied for their anti-inflammatory activity using the transcription factor NF-kappa B as molecular target. NF-kappa B is involved in the synthesis of inflammatory mediators, such as cytokines and chemokines. NF-kappa B DNA binding was inhibited at micromolar concentrations by all Sls.
- Published
- 2000
- Full Text
- View/download PDF
87. Anti-inflammatory activities of hypocretenolides from Leontodon hispidus.
- Author
-
Zidorn C, Dirsch VM, Rüngeler P, Sosa S, Della Loggia R, Merfort I, Pahl HL, Vollmar AM, and Stuppner H
- Subjects
- Animals, Anti-Inflammatory Agents, Non-Steroidal chemistry, Anti-Inflammatory Agents, Non-Steroidal isolation & purification, Cell Line, DNA metabolism, Humans, Jurkat Cells, Mice, NF-kappa B metabolism, Nitrites metabolism, Sesquiterpenes chemistry, Sesquiterpenes isolation & purification, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Plants, Medicinal chemistry, Sesquiterpenes pharmacology
- Abstract
Hypocretenolides, a small group of sesquiterpene lactones with an unusual ring structure, are constituents of a small number of species from the Lactuceae tribe (Asteraceae). Three biogenetically closely related 14-hypocretenolides from Leontodon hispidus L. were investigated for a putative anti-inflammatory activity. 14-Hydroxyhypocretenolide-beta-D-glucoside-4'-14"-hydroxyhypocr etenoate significantly exhibited in vivo anti-inflammatory activity in the croton oil-induced mouse ear edema. To obtain first information regarding the molecular targets which might be affected by this constituent, two in vitro bioassays were performed: (i) DNA binding activity of the transcription factor NF-kappa B was evaluated by electrophoretic mobility shift assay (EMSA) using TNF-alpha-activated Jurkat T cells and (ii) nitrite accumulation in cell culture supernatants of LPS-activated RAW 264.7 macrophages was determined as a parameter for inducible nitric oxide synthase (iNOS)-dependent nitric oxide release. In order to gain information about structure-activity relationships, additionally the aglycone 14-hydroxyhypocretenolide and its D-glycoside were investigated in these in vitro systems. 14-Hydroxyhypocretenolide-beta-D-glucoside-4'-14"-hydroxyhypocr etenoate as well as its aglycone exhibited activity in both test systems, whereas the D-glucoside was not or only weakly active.
- Published
- 1999
- Full Text
- View/download PDF
88. Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions.
- Author
-
Schmidt TJ, Lyss G, Pahl HL, and Merfort I
- Subjects
- Binding Sites, Cysteine chemistry, Hydrogen-Ion Concentration, Kinetics, Magnetic Resonance Spectroscopy, Models, Chemical, NF-kappa B antagonists & inhibitors, Sesquiterpenes, Guaiane, Spectrophotometry, Ultraviolet, Glutathione metabolism, Lactones chemistry, Lactones metabolism, Sesquiterpenes chemistry, Sesquiterpenes metabolism
- Abstract
Sesquiterpene lactones (STLs) are known to exert most of their numerous biological activities through inhibition of enzymes and other functional proteins by forming covalent bonds with free cysteine residues in these macromolecules. The question arises how these drugs can alkylate such vital target structures instead of being quickly deactivated by reaction with the cysteine group of glutathione (GSH) which is present in high concentrations in all cells. We have measured in this study the pH dependent kinetics of GSH addition to the cyclopentenone and alpha-methylene-gamma-lactone group of helenanolide type sesquiterpene lactones using UV-spectrophotometry. The reaction with GSH at physiological pH proceeds very quickly but is reversible so that a fraction of STL molecules will always be available for reaction with protein targets. In agreement with these chemical data, helenalin-mono- and -bis-glutathionyl adducts were demonstrated to inhibit the nuclear transcription factor NF-kappaB at concentrations similar to the free sesquiterpene lactone.
- Published
- 1999
- Full Text
- View/download PDF
89. Activators and target genes of Rel/NF-kappaB transcription factors.
- Author
-
Pahl HL
- Subjects
- Animals, DNA metabolism, Humans, Immunity, NF-kappa B drug effects, Stress, Physiological physiopathology, NF-kappa B physiology
- Abstract
The vertebrate transcription factor NF-kappaB is induced by over 150 different stimuli. Active NF-kappaB, in turn, participates in the control of transcription of over 150 target genes. Because a large variety of bacteria and viruses activate NF-kappaB and because the transcription factor regulates the expression of inflammatory cytokines, chemokines, immunoreceptors, and cell adhesion molecules, NF-kappaB has often been termed a 'central mediator of the human immune response'. This article contains a complete listing of all NF-kappaB inducers and target genes described to date. The collected data argue that NF-kappaB functions more generally as a central regulator of stress responses. In addition, NF-kappaB activation blocks apoptosis in several cell types. Coupling stress responsiveness and anti-apoptotic pathways through the use of a common transcription factor may result in increased cell survival following stress insults.
- Published
- 1999
- Full Text
- View/download PDF
90. Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action.
- Author
-
Rüngeler P, Castro V, Mora G, Gören N, Vichnewski W, Pahl HL, Merfort I, and Schmidt TJ
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal pharmacology, Humans, Jurkat Cells, Models, Molecular, Plant Extracts pharmacology, Structure-Activity Relationship, Lactones pharmacology, NF-kappa B antagonists & inhibitors, Sesquiterpenes pharmacology
- Abstract
Many sesquiterpene lactones (SLs) possess considerable anti-inflammatory activity. They inhibit the transcription factor NF-kappaB by selectively alkylating its p65 subunit probably by reacting with cysteine residues. Here we assayed 28 sesquiterpene lactones for their ability to inhibit NF-kappaB. The majority of the potent NF-kappaB inhibitors possess two reactive centers in form of an alpha-methylene-gamma-lactone group and an alpha,beta- or alpha,beta,gamma,delta-unsaturated carbonyl group. Based on computer molecular modelling we propose a molecular mechanism of action, which is able to explain the p65 selectivity of the SLs and the observed correlation of high activity with alkylant bifunctionality. A single bifunctional SL molecule can alkylate the cysteine residue (Cys 38) in the DNA binding loop 1 (L1) and a further cysteine (Cys 120) in the nearby E' region. This cross link alters the position of tyrosine 36 and additional amino acids in such a way that their specific interactions with the DNA become impossible. We also created a model for monofunctional SLs.
- Published
- 1999
- Full Text
- View/download PDF
91. Signal transduction from the endoplasmic reticulum to the cell nucleus.
- Author
-
Pahl HL
- Subjects
- Animals, DNA-Binding Proteins physiology, NF-kappa B physiology, Nuclear Proteins physiology, Sterol Regulatory Element Binding Protein 1, CCAAT-Enhancer-Binding Proteins, Cell Nucleus physiology, Endoplasmic Reticulum physiology, Signal Transduction physiology, Transcription Factors
- Abstract
The endoplasmic reticulum (ER) serves several important functions. Cholesterol, an essential component of cellular membranes, is synthesized on the ER surface. Inside the organelle, proteins destined for secretion or transport to the cell surface are folded and become glycosylated. Because these processes are essential for cell viability, a disturbance in ER function presents significant stress to the cell. In response to ER stress, three distinct signal transduction pathways can be activated. Two of these, the unfolded protein response and the ER-overload response, respond to disturbances in protein processing. The third, the sterol regulatory cascade, is activated by depletion of cholesterol. This review summarizes the recent advances in our understanding of these ER-nuclear signal transduction pathways. In addition, it points to novel regulatory mechanisms discovered in these pathways, which may be widely used in other systems.
- Published
- 1999
- Full Text
- View/download PDF
92. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis.
- Author
-
von Leoprechting A, van der Bruggen P, Pahl HL, Aruffo A, and Simon JC
- Subjects
- Adjuvants, Immunologic metabolism, CD40 Antigens biosynthesis, Cell Division, Cytokines immunology, Cytokines physiology, Humans, In Situ Hybridization, Lymphocyte Subsets immunology, Melanoma metabolism, NF-kappa B immunology, NF-kappa B metabolism, Signal Transduction, Transcription Factors metabolism, Tumor Cells, Cultured, Up-Regulation, Apoptosis immunology, CD40 Antigens immunology, Melanoma immunology, T-Lymphocytes, Cytotoxic immunology
- Abstract
Here, we report the functional expression of CD40 on human malignant melanomas (MMs). Comparison of tumor specimen from MM precursor lesions, primary tumors, and metastases revealed that CD40 surface expression is down-regulated during tumor progression. CD40 expression was confirmed in 7 human MM cell lines established from immunogenic primary tumors or metastases, whereas 11 cell lines established from advanced stages were CD40 negative. CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering. CD40 ligation on MM by CD40L-transfected murine L-cells or by a soluble CD40L fusion protein up-regulated their expression of intercellular adhesion molecule-1 and MHC class I and class II molecules and their secretion of IL-6, IL-8, tumor necrosis factor-a, and granulocyte macrophage colony-stimulating factor and also induced a rapid activation of the transcription factor nuclear factor kappaB. Furthermore, CD40 ligation of a HLA-A2+, MelanA/MART1+ MM cell line enhanced its susceptibility to specific lysis by a HLA-A2-restricted, MelanA/MART-1-specific CTL clone. Finally, CD40 ligation induced growth inhibition and apoptosis in MM. These results indicate that CD40-CD40L interactions may play an important role in augmenting antitumor immunity and inducing apoptosis in some CD40-positive immunogenic human MMs.
- Published
- 1999
93. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion.
- Author
-
Sembries S, Pahl H, Stilgenbauer S, Döhner H, and Schriever F
- Subjects
- Antigens, CD analysis, Antigens, Differentiation, T-Lymphocyte analysis, Apyrase, CD11 Antigens analysis, CD18 Antigens analysis, CD48 Antigen, CD58 Antigens analysis, Humans, Integrin alpha4, Leukemia, Lymphocytic, Chronic, B-Cell mortality, Leukocyte Common Antigens analysis, NF-kappa B analysis, Platelet Endothelial Cell Adhesion Molecule-1 analysis, Receptors, Complement 3b analysis, Survival Rate, Adenosine Triphosphatases, Cell Adhesion Molecules analysis, Chromosomes, Human, Pair 11, Gene Deletion, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Leukemia, Lymphocytic, Chronic, B-Cell metabolism, Signal Transduction genetics
- Abstract
Deletions in chromosome bands 11q22-q23 were recently shown to be one of the most frequent chromosome aberrations in B-cell chronic lymphocytic leukemia (B-CLL). Patients suffering from B-CLL with 11q deletion are characterized by extensive lymphadenopathy, rapid disease progression, and short survival times. Phenotypic and functional characteristics of B-CLL cells with 11q deletion that may help to explain the pathophysiology of this entity are yet unknown. In the present study, B-CLL cells with (n = 19) and without (n = 19) 11q deletion were analyzed for their expression of functionally relevant cell surface molecules (n = 57). B-CLL cells with 11q deletion carried significantly lower levels of the adhesion molecules CD11a/CD18 (integrin alphaL/beta2), CD11c/CD18 (integrin alphaX/beta2), CD31 (PECAM-1), CD48, and CD58 (LFA-3). Furthermore, B-CLL cells with 11q deletion expressed less the cell signaling receptors CD45 (leukocyte common antigen [LCA]), CD6, CD35 (complement receptor 1), and CD39. Reduced CD45 levels and low-level expression of CD49d correlated with decreased overall survival. B-CLL cells with or without 11q deletion did not differ in their growth fractions, expression levels of transcription factor NF-kappaB, or their response to mitogenic stimuli. Decreased levels of functionally relevant adhesion molecules and of cell signaling receptors may contribute to the pathogenesis of the subgroup of B-CLL characterized by 11q22-q23 deletion.
- Published
- 1999
94. Study of three sesquiterpene lactones from Tithonia diversifolia on their anti-inflammatory activity using the transcription factor NF-kappa B and enzymes of the arachidonic acid pathway as targets.
- Author
-
Rüngeler P, Lyss G, Castro V, Mora G, Pahl HL, and Merfort I
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal chemistry, Anti-Inflammatory Agents, Non-Steroidal isolation & purification, Cyclooxygenase 1, Enzyme Inhibitors chemistry, Enzyme Inhibitors isolation & purification, Enzyme Inhibitors pharmacology, Humans, Isoenzymes drug effects, Jurkat Cells, Lactones chemistry, Lactones isolation & purification, Lactones pharmacology, Membrane Proteins, Molecular Structure, Phospholipases A2, Plants, Medicinal chemistry, Prostaglandin-Endoperoxide Synthases drug effects, Sesquiterpenes chemistry, Sesquiterpenes isolation & purification, Sesquiterpenes pharmacology, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Asteraceae chemistry, NF-kappa B metabolism, Phospholipases A antagonists & inhibitors
- Abstract
In Central America leaf extracts from the Asteraceae Tithonia diversifolia are used externally for the treatment of haematomas and wounds. Therefore, the main sesquiterpene lactones (Sls) of this species growing in Costa Rica, diversifolin (1), diversifolin methyl ether (2), and tirotundin (3), were studied for their anti-inflammatory activity. We determined whether these compounds inhibit cyclooxygenase-I, phospholipase A2, or the transcription factor NF-kappa B. Here we show that these Sls do not influence the enzymes of the arachidonic acid pathway, but inhibit the activation of NF-kappa B. Thereby, the synthesis of inflammatory mediators such as cytokines and chemokines is reduced. Our results indicate that the inhibitory activity of compounds 1-3 is due to alkylation of cysteine residues, which are probably located in the DNA binding domain of NF-kappa B. The Sls were also studied for their antibacterial activity, but only Sl 1 was moderately active against Bacillus subtilis in the agar plate diffusion test.
- Published
- 1998
- Full Text
- View/download PDF
95. Pericardial effusion in glycanosis CDG type I (MIM 212 065): an inflammatory endoplasmic reticulum overload response?
- Author
-
Heyne K, Mayatepek E, Walther F, Weidinger S, and Pahl HL
- Subjects
- Female, Glycosylation, Humans, Infant, Male, Pericardial Effusion pathology, Proteins metabolism, Congenital Disorders of Glycosylation complications, Endoplasmic Reticulum metabolism, NF-kappa B metabolism, Pericardial Effusion etiology
- Published
- 1998
96. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB.
- Author
-
Lyss G, Schmidt TJ, Merfort I, and Pahl HL
- Subjects
- B-Lymphocytes drug effects, Blotting, Western, DNA-Binding Proteins chemistry, Electrophoresis, Polyacrylamide Gel, Gene Expression Regulation drug effects, Gene Expression Regulation genetics, HeLa Cells, Humans, Jurkat Cells drug effects, NF-KappaB Inhibitor alpha, NF-kappa B chemistry, NF-kappa B genetics, Phosphorylation, Plant Extracts pharmacology, Sesquiterpenes, Guaiane, Structure-Activity Relationship, T-Lymphocytes drug effects, Transfection, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Antineoplastic Agents, Phytogenic pharmacology, Arnica, I-kappa B Proteins, NF-kappa B antagonists & inhibitors, Plants, Medicinal, Sesquiterpenes pharmacology
- Abstract
Alcoholic extracts prepared form Arnicae flos, the collective name for flowerheads from Arnica montana and A. chamissonis ssp. foliosa, are used therapeutically as anti-inflammatory remedies. The active ingredients mediating the pharmacological effect are mainly sesquiterpene lactones, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives. While these compounds affect various cellular processes, current data do not fully explain how sesquiterpene lactones exert their anti-inflammatory effect. We show here that helenalin, and, to a much lesser degree, 11alpha,13-dihydrohelenalin and chamissonolid, inhibit activation of transcription factor NF-kappaB. This difference in efficacy, which correlates with the compounds' anti-inflammatory potency in vivo, may be explained by differences in structure and conformation. NF-kappaB, which resides in an inactive, cytoplasmic complex in unstimulated cells, is activated by phosphorylation and degradation of its inhibitory subunit, IkappaB. Helenalin inhibits NF-kappaB activation in response to four different stimuli in T-cells, B-cells and epithelial cells and abrogates kappaB-driven gene expression. This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was not affected. We show that inhibition is not due to a direct modification of the active NF-kappaB heterodimer. Rather, helenalin modifies the NF-kappaB/IkappaB complex, preventing the release of IkappaB. These data suggest a molecular mechanism for the anti-inflammatory effect of sesquiterpene lactones, which differs from that of other nonsteroidal anti-inflammatory drugs (NSAIDs), indomethacin and acetyl salicylic acid.
- Published
- 1997
- Full Text
- View/download PDF
97. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
- Author
-
Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Pahl H, and Fateh-Moghadam A
- Subjects
- Colorectal Neoplasms mortality, Humans, Multivariate Analysis, Prognosis, Retrospective Studies, Survival Rate, CA-19-9 Antigen blood, Carcinoembryonic Antigen blood, Colorectal Neoplasms blood
- Abstract
Unlabelled: The prognostic information provided by preoperative serum CEA, CA 19-9 antigen assays as compared with the classical prognostic factors (age, sex, tumor infiltration, tumor stage (Dukes') and R-classification) in 495 patients with colorectal carcinoma was analysed., Patients and Methods: Survival function estimates were calculated according to Kaplan-Meier. The patients were separated into two groups according to the preoperative marker levels. Fixing specificity at 100% for healthy people, cut off levels were calculated. Survival curve differences were assessed using the log-rank-test. Multivariate Cox's proportional hazard regression analysis was performed. The Mantel-Haenszel method was used to assess the survival rate of patients with colorectal carcinoma and high versus low levels of tumor-associated antigens according to tumor stages. The study was performed on the frozen sera (stored at -80 degrees C) of 495 patients with histologically proven colorectal carcinoma., Results: The Dukes' stages (log-rank chi-square = 231.9; P < 0.0001) represent the best prognostic factor besides the preoperative values of CA 19-9 (log-rank chi-square = 162.5). CEA shows a log-rank chi-square of 71.4. Thus, CEA and CA 19-9 can be used to discriminate two groups of patients with significantly different survival times (P < 0.0001). The importance of different parameters in providing additional prognostic information was evaluated by multivariate analysis (Cox's model). Estimated relative risks of death adjusted for tumor stage were 5.5 for Dukes' stage A versus Dukes' stage B/C and Dukes' stage B/C versus Dukes' stage D, respectively and an increasing relative risk of 27.5 for Dukes' stage A versus Dukes' stage D (P < 0.001). The relative risk for preoperative CA 19-9 serum concentrations (> or = 60 U/mL versus < 60 U/mL) was 2.3 (P < 0.001) for preoperative CEA concentrations (> or = 4 ng/mL versus < 4 ng/mL) 1.4 (P < 0.07). For CEA the 2-years survival rates in the group of patients with preoperative serum concentrations > or = 4 ng/mL versus < 4 ng/mL and Dukes' stage D were 16% versus 38%, in Dukes' stage B/C 73% versus 91% and in Dukes' stage A 100% versus 98%. For CA 19-9 the 2-years survival rates in the group of patients with preoperative serum concentrations > or = 60 U/mL versus < 60 U/mL and Dukes' stage D were 10% versus 39%, in Dukes' stage B/C 58% versus 87%. In the group of patients with Dukes' stage A with serum levels > or = 60 U/mL a 2-year survival rate of 100% was found. In the corresponding group only one patient exists., Conclusion: The postoperative Dukes' classification provides the best prognostic information besides the preoperative values of CA 19-9. The predictive information provided by the preoperative CA 19-9 serum level is additional to that obtained from the other factors investigated.
- Published
- 1997
98. The ratio of free to total prostate specific antigen: an advantageous addition in the differential diagnosis of benign hyperplasia and cancer of the prostate?
- Author
-
Reiter W, Stieber P, Schmeller N, Nagel D, Jansen HM, Schambeck C, Fabricius PG, Pahl H, Mattes M, Constabel H, and Fateh-Moghadam A
- Subjects
- Diagnosis, Differential, Humans, Male, Sensitivity and Specificity, Prostate-Specific Antigen blood, Prostatic Hyperplasia diagnosis, Prostatic Neoplasms diagnosis
- Abstract
Unlabelled: This study examined the clinical relevance of the determination of free PSA (f-PSA) in addition to total PSA (t-PSA)., Patients and Methods: Both total PSA- and free PSA-values of frozen sera obtained pretherapeutically from 80 patients with carcinoma (PC) and 171 patients with benign hyperplasia of the prostate (BPH) were analysed by means of PSA IRMA and FREE PSA IRMA (IMMUNOCORP/IBL)., Results: At 95% specificity (true negative test results), a cut-off value of 16.8 [micrograms/L] was obtained for total PSA (9 patients with BPH [5%] were above this value). For this cut-off value we calculated a sensitivity (true positive test results) of 41%. Using the same criteria for the ratio Q = f-PSA:t-PSA a cut-off of 0.083 was found again at a specificity of 95%. In a second step only patients with total PSA values below the cut-off level of 16.8 [micrograms/L]) were considered. Of these patients 11 of 160 with BPH (missing values = 1) and 13 of 33 with PC (missing values = 2) were below the above mentioned ratio (Q = 0.083). Considering both steps (total PSA and Q) 46 patients with PC were detected correctly and 20 patients with BPH would have been biopsied unnecessarily (positive biopsy rate: 70%)., Conclusion: High total PSA levels are a very good indicator for the presence of prostate cancer. There is still concern to improve the differentiation between the diagnosis between BPH and PC, when an intermediate or low value (< or = 95% specificity) is observed. The determination of Q is only useful in this range and might be helpful for the clinician's decision to apply or avoid biopsy.
- Published
- 1997
99. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
- Author
-
Poley S, Stieber P, Nüssler V, Pahl H, and Fateh-Moghadam A
- Subjects
- CD56 Antigen blood, Humans, Prognosis, Retrospective Studies, Biomarkers, Tumor blood, Multiple Myeloma blood, Neural Cell Adhesion Molecules blood
- Abstract
Serum neural cell adhesion molecule (NCAM), a possible prognostic marker for multiple myeloma (MM), was determined by means of an enzyme immunoassay, which showed good linearity and high precision. In 95% of healthy controls (n = 70), NCAM values were below 18.7 U/mL. In patients with monoclorlal gammopathies of undetermined significance (MGUS) (n = 31) or polyclonal gammopathies (n = 53) the cut off was 23.1 U/mL. MM in active stage (n = 52) showed significantly higher NCAM levels (p < 0.001) than in asymptomatic stage (n = 44). In active myeloma the sensitivity of serum markers were found to be: NCAM 40%, beta 2-microglobulin beta 2-M) 52% and serum thymidine-kinase (S-TK) 41% (cut off defined on MGUS). The combined sensitivities ranged between 55 and 60% (NCAM+ beta 2-M, beta 2-M+S-TK, NCAM+S-TK). No correlation with beta 2-M or S-TK could be demonstrated. However, NCAM values were correlated with the concentration of monoclonal immunoglobulin (IgG-paraprotein: r = 0.45; IgA-paraprotein: r = 0.58). In the follow-up of patients with myeloma, NCAM values decreased in response to chemotherapy and were low in smouldering myeloma. But in three patients with progression NCAM did not reflect the tumor activity. At the time of censor, 80% of patients (n = 80) with a pre-treatment NCAM of < 18.5 U/mL and 61% of patients with a NCAM of > 18.5 U/mL were still alive. NCAM showed a low prognostic significance (log-rank: p < 0.07). Seven of ten myeloma patients with CD56 expression on plasma cell surface, which was examined by flow cytometry, displayed a high concentration of NCAM in serum. All other non-Hodgkin's lymphomas (21 immunocytoma, 27 chronic lymphocytic leukemia, 16 centrocytic/centroblastic-centrocytic lymphoma, 24 high-grade lymphoma) had low NCAM concentrations in serum and did not significantly vary in follow-up. In conclusion, serum NCAM could be a marker for the staging and monitoring of MM. However, it seems, that NCAM did not provide additional prognostic information relating to beta 2-M, S-TK or paraprotein.
- Published
- 1997
100. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
- Author
-
Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, and Fateh-Moghadam A
- Subjects
- Humans, Multivariate Analysis, Neoplasm Staging, Prognosis, Stomach Neoplasms mortality, Stomach Neoplasms pathology, Survival Rate, Antigens, Tumor-Associated, Carbohydrate blood, Biomarkers, Tumor blood, CA-19-9 Antigen blood, Carcinoembryonic Antigen blood, Stomach Neoplasms blood
- Abstract
Unlabelled: We studied the relevance of CEA, CA 19-9, CA 72-4 and the common classical prognostic factors (age, sex, tumor infiltration, N-classification, staging, grading and Lauren classification) in gastric carcinoma., Patients and Methods: Survival function estimates were calculated according the method to Kaplan-Meier. The patients were separated into two groups according to preoperative marker levels. Fixing specificity at 100% for healthy people, cut off levels were calculated. Survival curve differences were assessed using the log-rank-test. Multivariate Cox proportional hazards regression analysis was performed. The mantel-Haenszel method was used to assess the 2-year survival rate of patients with gastric carcinoma and high versus low levels of tumor-associated antigens adjusted to tumor stages. The study was performed on the frozen sera (stored at -80 degrees C) of 103 patients with histologically proven gastric carcinoma., Results: The tumor stage (log-rank chi-square = 55.9; P < 0.0001) represents the best prognostic factor besides preoperative values of CA 19-9 (log-rank chi-square = 13.9; P < 0.001) and CEA (log-rank chi-square = 12.2; P < 0.001). CA 72.4 shows a log-rank chi-square of 6.9 (P < 0.01). We found no statistically significant correlation between survival and sex, tumor grade and Lauren classification. The importance of different parameters in providing additional prognostic information was evaluated by multivariate analysis. Only patients after curative surgical intervention (n = 55, R0) were considered. Cox proportional hazards regression analysis yielded an adjusted relative risk of 2.4 in patients with a preoperative CEA concentrations > or = 4 ng/mL vs. < 4 ng/mL, of 2.8 in patients with a preoperative CA 19-9 concentration > or = 60 U/mL vs. < CA 19-9 and of 1.8 for stage III/IV vs. stage I/II (P < 0.05). For CEA the 2-year survival rates in the group of patients with preoperative serum concentrations > or = 4 ng/mL versus < 4 ng/mL and stadium III/IV were 14% versus 29% and in stadium I/II 50% versus 83% (P < 0.05). For CA 19-9 the 2-years survival rates in the group of patients with preoperative serum concentrations > or = 60 U/mL versus < 60 U/mL and stadium III/IV were 14% versus 28% and in stadium I/II 40% versus 83% (P < 0.05)., Conclusion: The postoperative R-classification and the tumor stage represent the best prognostic information besides the preoperative values of CA 19-9 or CEA, respectively. The predictive information provided by preoperative CEA and CA 19-9 serum levels is additional to that obtained from other factors investigated.
- Published
- 1997
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.